Synthesis of Two Precursors of Heterocarbocyclic Nucleoside Analogues
FULL PAPER
–
1 1
bonate (1.88 g, 13.60 mmol) was added to a 1:1 solution of 15/16
(film): ν˜ = 3344, 2925, 1654, 1560, 1504, 1458, 1040 cm . H NMR
]MeOH): δ = 7.36 (d, J = 5.02 Hz, 1 H, 2-H), 7.01
(d, J = 5.02 Hz, 1 H, 3-H), 4.49–4.41 (m, 1 H, 4-H), 3.68–3.49 (m,
3 H, OCH +6-H), 2.61–2.49 (m, 1 H, 5-H), 2.42–2.31 (m, 1 H, 5-
(
0.92 g, 3.64 mmol) in MeOH (12 mL), and the mixture was stirred (300 MHz, [D
for 2.5 h at room temperature and brought to pH 7 by addition of
saturated NH Cl solution (40 mL). The organic solvent was re-
4
4
2
3
1
moved under reduced pressure, and the solid formed was redis-
solved in water (60 mL). This solution was extracted with EtOAc
H) ppm. C NMR (75 MHz, [D
(C-3a,-6a), 129.48 (C-2), 121.09 (C-3), 65.86 (CH
43.55 (C-6), 42.23 (C-5) ppm. EIMS: m/z (%) = 169 (12) [M ], 168
(3) [M – 1] , 152 (7) [M – OH], 138 (100) [C
(24). HMRS m/z calcd. for [C 11NOS] 169.0561, found 169.0571.
4
]MeOH): δ = 147.05 and 146.11
2
O), 51.79 (C-4),
+
(
3×60 mL), and the combined organic extracts were dried with an-
hydrous Na SO and concentrated under reduced pressure. The so-
lid residue so obtained was chromatographed on silica gel (22 g)
with CH Cl /iPrOH (15:1) as eluent, it afforded first 17 (0.33 g,
3%) and then 18 (0.29 g, 38%).
+
+
2
4
7 8
H SN], 123 (6), 122
8
H
2
2
Supporting Information (see footnote on the first page of this arti-
cle): The ORTEP plot of the structure of (±)-16 and the details of
the reduction of hydroxyimino ester 14 is available.
4
1
1
1
7: M.p. 155–157 °C. IR (KBr): ν˜ = 3276, 2964, 1635, 1553, 1372,
–1 1
041 cm . H NMR (300 MHz, CDCl
3
): δ = 7.23 (d, J = 4.9 Hz,
H, 2-H), 6.87 (d, J = 4.9 Hz, 1 H, 3-H), 6.35 (d, J = 7.6 Hz, 1
H, NH), 5.31 (dt, J = 8.4, J = 3.1 Hz, 1 H, 4-H), 3.86 and 3.69
AB part of an ABM system, JAB = 10.4, JAM = 4.3, JBM = 3.5 Hz,
Acknowledgments
(
2
8
H, OCH
.4 Hz, 5-H), 2.21 (br. s, D
2
), 3.42–3.36 (m, 1 H, 6-H), 3.11 (dt, 1 H, J = 13.8, J =
O exch., 1 H, OH), 1.99 (dt, J = 13.8,
) ppm. 13C NMR (75 MHz,
): δ = 169.72 (CO), 147.98 and 145.14 (C-3a,-6a), 130.26 (C-
), 122.21 (C-3), 66.16 (CH O), 49.79 (C-4), 43.50 (C-6), 42.09 (C-
), 23.82 (CH ) ppm. EIMS: m/z (%) = 152 (0.23) [C 10SN], 138
SN], 122 (16), 58 (100). C10 S (211.28): calcd. C
The authors thank the Xunta de Galicia for financial support un-
der projects PGIDT01 PXI20302PR and PGIDT02BTF20305PR.
2
J = 3.3 Hz, 1 H, 5-H), 1.92 (s, 3 H, CH
CDCl
2
5
3
3
2
[1] a) J. M. Colacino, K. A. Staschke, Prog. Drug. Res. 1998, 50,
259–322; b) M. V. Kolb, Prog. Drug. Res. 1997, 48, 195–232; c)
E. De Clercq, Curr. Med. Chem. 2001, 8, 1543–1572; d) H. Tan,
C. K. Chu, F. D. Boudinot, Adv. Drug Delivery Rev. 1999, 39,
3
8
H
(11) [C
7
H
8
H13NO
2
5
1
6.85, H 6.20, N 6.63, S 15.18; found C 57.11, H 6.11, N 6.68, S
5.07.
117–151; e) T. S. Mansour, R. Storer, Curr. Pharmaceutical De-
sign 1997, 3, 227–264.
1
1
5
6
8: M.p. 94–96 °C. IR (KBr): ν˜ = 3531, 3254, 2925, 1612, 1562,
261, 1057 cm . H NMR (300 MHz, CDCl ): δ = 7.24 (d, J =
3
.0 Hz, 1 H, 2-H), 6.88 (d, J = 5.0 Hz, 1 H, 3-H), 5.77 (d, J =
.4 Hz, 1 H, NH), 5.39–5.33 (m, 1 H, 4-H), 3.79–3.52 (m, 3 H,
[2] a) E. Ichicawa, K. Kato, Curr. Med. Chem. 2001, 8, 385–423;
b) X.-F. Zhu, Nucleosides, Nucleotides Nucleic Acids 2000, 19,
–1 1
651–690; c) M. T. Crimmins, Tetrahedron 1998, 54, 9229–9272;
d) L. Agrofoglio, E. Suhas, A. Farese, R. Condom, S. R. Chal-
land, R. A. Earl, R. Guedj, Tetrahedron 1994, 50, 10611–10670.
3] a) Y. F. Shealy, J. D. Clayton, J. Am. Chem. Soc. 1966, 88,
OCH
2
, 6-H), 2.67 (ddd, Jgem = 13.8, Jvic = 7.8, Jvic = 4.7 Hz, 1 H,
[
5
2
-H), 2.35 (ddd, Jgem = 13.8, Jvic = 7.8, Jvic = 4.1 Hz, 1 H, 5-H),
.02 (br. s, D
3885–3887; b) Y. F. Shealy, J. D. Clayton, J. Am. Chem. Soc.
1
3
2
O exch., 1 H, OH), 1.97 (s, 3 H, CH
): δ = 169.98 (CO), 147.87 and 146.98 (C-
a,-6a), 130.26 (C-2), 121.98 (C-3), 66.83 (CH O), 50.80 (C-4),
3.61 (C-6), 42.30 (C-5), 23.76 (CH ) ppm. EIMS: m/z (%) = 193
O], 168 (3) [M – Ac], 152 (46) [C 10SN], 138 (100)
SN], 122 (66) ppm. C10 S (211.28): calcd. C 56.85, H
3
) ppm.
C
1
969, 91, 3075–3083; c) Y. F. Shealy, J. D. Clayton, J. Pharm.
NMR (75 MHz, CDCl
3
4
3
Sci. 1973, 62, 1432.
2
[4] T. Kusaka, H. Yamamoto, M. Shibata, M. Muroi, T. Kishi,
K. T. Mizuno, J. Antibiot. 1968, 21, 255–261.
[5] S. Yaginuma, N. Muto, M. Tsujino, Y. Sudate, M. Hayashi, M.
Otani, J. Antibiot. 1981, 34, 359–366.
3
+
+
(33) [M – H
2
8
H
[C
7
H
8
H13NO
2
[
[
6] R. Vince, M. Hua, J. Med. Chem. 1990, 33, 17–21.
6
.20, N 6.63, S 15.18; found C 56.94, H 6.26, N 6.59, S 15.09.
7] a) M. B. Faletto, W. H. Miller, E. P. Garvey, M. H. St. Clair,
S. M. Daluge, S. S. Good, Antimicrob. Agents Chemother. 1997,
41, 1099–1107; b) R. H. Foster, D. Faulds, Drugs 1998, 729–
3
.1.9 (±)-cis-(4-Amino-5,6-dihydro-4H-cyclopenta[b]thien-6-yl)meth-
anol (6): A solution of 17 (0.132 g, 0.78 mmol) in a mixture of
MeOH (3 mL) and 2 n HCl (3 mL) was refluxed for 8 h and then
reduced to dryness by evaporation under reduced pressure followed
by azeotropic distillation with EtOH (2×20 mL). The solid residue
was dissolved in MeOH (4 mL), loaded on a 10 mL Amberlite
IRA-400(OH) column, and eluted with MeOH (100 mL). Concen-
tration of the eluate under reduced pressure left an oily residue that
afforded 6 (0.042 g, 40%) as an orange oil after chromatography
on silica gel (8 g) with dichloromethane/methanol (1:1) as eluent .
736; c) S. M. Daluge, M. T. Martín, B. R. Sickles, D. A. Living-
ston, Nucleosides, Nucleotides Nucleic Acids 2000, 19, 297–327.
8] a) D. F. Ewing, N.-E. Fahmi, C. Len, G. Mackenzie, A. Prauzo,
J. Chem. Soc., Perkin 1 2000, 3561–3565; b) D. F. Ewing, N.-
E. Fahmi, C. Len, G. Mackenzie, G. Ronco, P. Villa, G. Shaw,
Nucleosides Nucleotides Nucleic Acids 1999, 18, 2613–2630.
9] L. Belmonte, P. Baré, M. M. E. De Bracco, B. H. Ruibal-Ares,
Curr. Med. Chem. 2003, 10, 303–312.
[
[
[10] a) M. J. Figueira, O. Caamaño, F. Fernández, J. M. Blanco,
Tetrahedron 2002, 58, 7233–7240; b) M. I. Nieto, O. Caamaño,
F. Fernández, G. Gómez, J. Balzarini, E. De Clercq, Nucleo-
sides, Nucleotides Nucleic Acids 2002, 21, 243–255; c) F.
Fernández, X. García-Mera, M. Morales, J.-E. Rodríguez-
Borges, Synthesis 2001, 239–242; d) M. I. Nieto, J. M. Blanco,
O. Caamaño, F. Fernández, C. López, X. García-Mera, J. Balz-
arini, E. De Clercq, Nucleosides, Nucleotides Nucleic Acids
–
1 1
IR (film): ν˜ = 3346, 2923, 1841, 1587, 1503, 1438, 1037 cm . H
NMR (300 MHz, [D ]MeOH): δ = 7.30 (d, J = 4.9 Hz, 1 H, 2-H),
.97 (d, J = 4.9 Hz, 1 H, 3-H), 4.34–4.29 (m, 1 H, 4-H), 3.78–3.52
m, 3 H, OCH , 6-H), 3.16–2.88 (m, 1 H, 5-H), 1.98–1.81 (m, 1 H,
-H) ppm. 13C NMR (75 MHz, [D
]MeOH): δ = 149.05 and 145.08
O), 52.09
C-4), 43.59 (C-6), 43.14 (C-5) ppm. EIMS: m/z (%) = 168 (0.62)
4
6
(
5
2
4
(C-3a,-6a), 129.05 (C-2), 121.04 (C-3), 65.72 (CH
2
(
1
999, 18, 2253–2263.
+
+
[M – 1] , 152 (6) [M – OH], 138 (100) [C
7 8
H SN], 123 (19), 122
[
11] a) J. M. Blanco, O. Caamaño, F. Fernández, J. E. Rodríguez-
(95). HMRS m/z calcd. for [C 11NOS] 169.0561, found 169.0569.
8
H
Borges, J. Balzarini, E. De Clercq, Chem. Pharm. Bull. 2003,
5
1, 1060–1063; b) J. M. Blanco, O. Caamaño, F. Fernández,
3
.1.10 (±)-trans-(4-Amino-5,6-dihydro-4H-cyclopenta[b]thien-6-yl)-
X. García-Mera, A. R.-Hergueta, C. López, J. E. Rodríguez-
methanol (7): A solution of 18 (0.104 g, 0.49 mmol) in a mixture
of EtOH (2.5 mL) and 2 n HCl (2.5 mL) was refluxed for 24 h.
Compound 7 (0.034 g, 41%) was obtained as a brown oil by a
procedure analogous to that by which 6 was obtained from 17. IR
Borges, J. Balzarini, E. De Clercq, Chem. Pharm. Bull. 1999,
47, 1314–1317.
[12] G. Ferrand, J. Barbanton, 1986. Depin, J. C. Fr. Demande FR
2567125, Chem. Abstr. 105: 172281.
Eur. J. Org. Chem. 2006, 759–764
© 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
763